GSA Capital Partners LLP Takes $138,000 Position in Asensus Surgical, Inc. (NYSEAMERICAN:ASXC)

GSA Capital Partners LLP acquired a new stake in Asensus Surgical, Inc. (NYSEAMERICAN:ASXCGet Rating) in the 1st quarter, HoldingsChannel reports. The fund acquired 220,679 shares of the company’s stock, valued at approximately $138,000.

Separately, Advisor Group Holdings Inc. boosted its holdings in shares of Asensus Surgical by 12.3% in the 1st quarter. Advisor Group Holdings Inc. now owns 279,923 shares of the company’s stock valued at $2,090,000 after buying an additional 30,676 shares during the last quarter.

Asensus Surgical Stock Performance

Shares of Asensus Surgical stock opened at $0.52 on Friday. Asensus Surgical, Inc. has a 1 year low of $0.35 and a 1 year high of $2.31.

Asensus Surgical (NYSEAMERICAN:ASXCGet Rating) last announced its quarterly earnings results on Monday, August 8th. The company reported ($0.08) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.08).

Wall Street Analyst Weigh In

Separately, HC Wainwright cut their price target on Asensus Surgical from $4.00 to $3.00 in a report on Wednesday, August 10th.

Asensus Surgical Company Profile

(Get Rating)

Asensus Surgical, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery.

See Also

Want to see what other hedge funds are holding ASXC? Visit to get the latest 13F filings and insider trades for Asensus Surgical, Inc. (NYSEAMERICAN:ASXCGet Rating).

Institutional Ownership by Quarter for Asensus Surgical (NYSEAMERICAN:ASXC)

Receive News & Ratings for Asensus Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Asensus Surgical and related companies with's FREE daily email newsletter.